Work

Triple Negative Breast Cancer – An Overview

Year: 2012
Type: article
Abstract: Triple Negative Breast Cancer (TNBC) is a heterogeneous disease that based on immunohistochemistry (IHC) is estrogen receptor (ER) negative, progesterone receptor (PR) negative and human epidermal growth factor receptor 2 (HER2) negative. TNBC is typically observed in young AA women and Hispanic women who carry a mutation in the BRCA1 gene. TNBC is characterized by a distinct molecular profile, aggressive nature and lack of targeted therapies. The purpose of this article is to review the current and future novel signalling pathways as therapeutic approaches to TNBC. Recent Identification of a new BRCA1 trafficking pathway holds promise in the future for the development of targeted therapies for TNBC.
Author: Kartik Aysola Akshata Desai
Language: English
Subfield: Cancer Research
Open Access status: hybrid
OpenAlex ID: W2111786429
FWCI: 0.501
Cites: 36
Cited by: 312
Related to: 10